/JPMorgan%20Chase%20%26%20Co_%20operations%20center-by%20jetcityimages%20via%20iStock.jpg)
With a market cap of $802.5 billion, JPMorgan Chase & Co. (JPM) is one of the world’s largest and most influential financial services firms. The company operates globally through key segments including Consumer & Community Banking, Corporate & Investment Banking, Commercial Banking, and Asset & Wealth Management. JPM is expected to announce its fiscal Q2 2025 earnings results before the market opens on Tuesday, Jul. 15.
Ahead of this event, analysts expect the New York-based company to report a profit of $4.47 per share, up 1.6% from $4.40 per share in the year-ago quarter. The company has surpassed Wall Street's earnings estimates in the last four quarters. In Q1 2025, JPM exceeded the consensus EPS estimate by 9.7%.
For fiscal 2025, analysts expect the financial services giant to report an EPS of $18.55, up 1.9% from $18.21 in fiscal 2024. Moreover, EPS is anticipated to grow 5.4% year-over-year to $19.55 in fiscal 2026.
Shares of JPMorgan have climbed 46.3% over the past 52 weeks, surpassing both the S&P 500 Index's ($SPX) 12.1% rise and the Financial Select Sector SPDR Fund's (XLF) 26.3% return over the same period.
Shares of JPMorgan Chase rallied 4% on Apr. 11 after reporting Q1 2025 results that beat expectations, with EPS of $5.07 surpassing the estimate and revenue rising 8.1% year over year to $45.3 billion. The bank also raised its full-year net interest income outlook to $94.5 billion. Strong segment performance further boosted investor sentiment, as markets revenue surged 19%, equities trading jumped 48%, and investment banking fees grew 12%.
Analysts' consensus view on JPMorgan’s stock is cautiously optimistic, with an overall "Moderate Buy" rating. Among 26 analysts covering the stock, 13 recommend "Strong Buy," three "Moderate Buys," and 10 suggest "Hold." This configuration is slightly more bullish than three months ago, with 12 analysts suggesting a "Strong Buy."
As of writing, JPM is trading above the average analyst price target of $273.84.
